Effects of FR167653 on pulmonary ischemia-reperfusion injury: administration timing.
Takeyoshi
I
I
Second Department of Surgery, Gunma University School of Medicine, Maebashi, Japan.
Otani
Y
Y
Koibuchi
Y
Y
Yokoe
T
T
Iino
Y
Y
Matsumoto
K
K
Muramoto
M
M
Satoh
S
S
Morishita
Y
Y
D000818:Animals; D007375:Interleukin-1 / Q000037:antagonists & inhibitors*; D008171:Lung Diseases / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D011720:Pyrazoles / Q000008:administration & dosage*; D011725:Pyridines / Q000008:administration & dosage*; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
C104334:FR 167653; D007375:Interleukin-1; D011720:Pyrazoles; D011725:Pyridines; D014409:Tumor Necrosis Factor-alpha